The International Collaborative Conference in Clinical Microbiology & Infectious Diseases

Size: px
Start display at page:

Download "The International Collaborative Conference in Clinical Microbiology & Infectious Diseases"

Transcription

1 The International Collaborative Conference in Clinical Microbiology & Infectious Diseases PLUS: Antimicrobial stewardship in hospitals: Improving outcomes through better education and implementation of effective interventions February 2015 Gulf Hotel, Kingdom of Bahrain Antimicrobial Stewardship Program (ASP) Speaker: Dr. Abdullah Almohaizeie

2 Objectives Discuss the essential elements of an antimicrobial stewardship program (ASP) business plan. Briefly discuss recent international and local ASP programs Outline current successful ASP activities at King Faisal Specialist Hospital and Research Center (KFSH&RC)

3 Antimicrobial Stewardship The rapid rise in antimicrobial resistance (AMR) has increased global momentum to establish antimicrobial stewardship programs in health facilities, clinics, and hospitals. The overuse or misuse of antimicrobial medicines is a key driver of AMR and a growing global health problem Antimicrobial stewardship programs can address inappropriate use of antimicrobials and help slow the spread of AMR through systems-level approaches supported by policies, structures, and interventions Holloway K, van dijk L. The World Medicines Situation 2011: Rational Use of Medicines, WHo, 2011 Guidelines for Antimicrobial Stewardship in Hospitals in Ireland. published on behalf of sari by HsE Health protection surveillance Centre, dublin, 2009

4 Antimicrobial Stewardship Comprehensive antimicrobial stewardship programs have demonstrated success in reducing inappropriate antimicrobial use by as much as 36% in hospitals in the United States. Although many countries have begun to adopt and promote antimicrobial stewardship policies and practices, these programs are largely absent from health facilities in the GCC countries Dellit et al. CID 2007

5 Antimicrobial Stewardship Programs Antimicrobial Management Programs (AMP) A marriage of infection control and antimicrobial management An activity that promotes: The appropriate selection of antimicrobials The appropriate dosing of antimicrobials The appropriate route and duration of antimicrobial therapy

6 Goals of Stewardship Programs The combination of effective antimicrobial stewardship with a comprehensive infection control program has been shown to limit the emergence of transmission of antimicrobial resistant bacteria A secondary goal of antimicrobial stewardship is to reduce healthcare costs without adversely impacting quality of care

7 Potential Active Core Strategies Prospective audit with intervention and feedback that can result in reduced inappropriate use (A-I) Formulary restriction and pre-authorization-can lead to significant and immediate reductions in antimicrobial use and cost (A-II)

8 Evidence-based Interventions Guidelines and clinical pathways (A-I) Dose optimization (A-II) IV to PO switch (A-I) De-escalation therapy (A-II) Education (A-III, B-II) Antimicrobial order forms (B-II) Antimicrobial cycling (no ranking) Delit et al. CID 2007; 44:

9 Feedback Audit ID Clinical pharmacist with ID consultant Targeted units and targeted drugs Review cases within hours of starting antimicrobial agents De-escalation Dose optimization IV to PO switch Bug-Drug mismatches

10 Antimicrobial Stewardship Guidelines Core Strategies Prospective audit with intervention and feedback Formulary restriction with preauthorization Supplemental Strategies Education Guidelines and clinical pathways Antimicrobial cycling Antimicrobial order forms Combination therapy Streamlining or de-escalation of therapy Dose optimization Parenteral to oral conversion Dellit et al. CID 2007.

11 Antimicrobial Stewardship Guidelines ID Clinical Pharmacist s Perspective: Allows needed FOCUS on a drug class Need to assure appropriate antimicrobial management and safety Assist with educational efforts Assist with formulary standardization Control costs

12 Identifying Best Practices Across Three Countries: Hospital Antimicrobial Stewardship in the United Kingdom, France, and the United States United Kingdom France United States Number of hospitals 2412 Approximately 2500 Approximately 5723 Antimicrobial stewardship characteristic Legislation Health and Social Care Act of 2008 mandates hospitals implement antimicrobial stewardship practices French Ministry of Health has required hospital antimicrobial stewardship programs since 2002 and annual public reporting of the hospital's compliance with specific antimicrobial stewardship performance indicators since 2007 Trivedi KK, Dumartin C, Gilchrist M, Wade P, Howard P. Clin Infect Dis October 15, Limited to California where the judicious use of antibiotics is required in general acute care hospitals since 2008 and also in Department of Veterans Affairs (VA) medical facilities where antimicrobial stewardship programs are required since in 2014

13 Identifying Best Practices Across Three Countries: Hospital Antimicrobial Stewardship in the United Kingdom, France, and the United States United Kingdom France United States Number of hospitals 2412 Approximately 2500 Approximately 5723 Antimicrobial stewardship characteristic Infrastructure Infection specialists manage and guide antimicrobial stewardship committees; on occasion, clinical pharmacists without ID training are involved with implementation Antibiotic advisor (physician, pharmacist, microbiologist, or infection preventionist with or without ID training) is responsible for implementation, in close collaboration with hospital pharmacists, microbiologists, and the antimicrobial stewardship committee Trivedi KK, Dumartin C, Gilchrist M, Wade P, Howard P. Clin Infect Dis October 15, Supported by ID physicians and ID pharmacists, but increasing number of non-id physicians and clinical pharmacists are leading programs when ID expertise may not be available

14 Identifying Best Practices Across Three Countries: Hospital Antimicrobial Stewardship in the United Kingdom, France, and the United States United Kingdom France United States Number of hospitals 2412 Approximately 2500 Approximately 5723 Antimicrobial stewardship characteristic Local strategies Local implementation of antimicrobial stewardship guidance provided in the Start Smart Then Focus program Local implementation of national guidance includes utilization of information technology resources, restricted antibiotic dispensation, practice audits, and education and feedback to prescribers Varies depending on personnel and administrative support; strategies range from post-prescription review and feedback performed by team to low-hanging fruit such as parenteral-to-oral conversion protocols implemented by clinical pharmacists Trivedi KK, Dumartin C, Gilchrist M, Wade P, Howard P. Clin Infect Dis October 15,

15 Identifying Best Practices Across Three Countries: Hospital Antimicrobial Stewardship in the United Kingdom, France, and the United States United Kingdom France United States Number of hospitals 2412 Approximately 2500 Approximately 5723 Antimicrobial stewardship characteristic Outcomes Recommended that hospitals monitor outcomes as outlined in the Start Smart Then Focus program, including annual monitoring and reporting of antimicrobial consumption trends Structure and process measures are included in composite indicator that is publicly reported annually; monitoring of antimicrobial utilization is required but not publicly reported; rates of specific resistant organisms are monitored as will Most hospitals monitor antimicrobial expenditures; other outcomes vary depending on available electronic systems; many hospitals follow process measures, some follow antimicrobial susceptibility patterns, and antimicrobial utilization if data accessible

16 The prevalence of antimicrobial resistance in clinical isolates from Gulf Corporation Council Countries Table 1 The data of selected clinical isolates reported by GCC countries Country Population Population % Reports (n) Reports% Isolates (n) Isolates% References Bahrain 1,106, % 3 9.1% % [4-6] Kuwait 2,583, % % % [7-15] Oman 3,173, % 3 9.1% % [8,16,17] Qatar 1,608, % 2 6.1% % [7,18] Saudi Arabia 25,373, % % % [19-32] UAE 4,765, % 2 6.1% % [33,34] GCC total 38,610, % % % n = 33 articles Aly M, Balkhy HH. Antimicrob Resist Infect Control. 2012; 1: 26

17 The prevalence of antimicrobial resistance in clinical isolates from Gulf Corporation Council Countries Table 2 The prevalence of resistant pathogens in clinical isolates from GCC countries Gram Negative Gram Positive Country Acinetobacter Escherichiaco Klebsiella li pneumoniae Pseudomonas Clostridium aeruginosa difficile Enterococcus MRSA Streptococcu s pneumoniae Bahrain N.R 14.0% 13.9% N.R N.R 76.5% 8.5% N.R Kuwait 16.7% 77.0% 36.2% 2.6% 70.0% N.R 3.3% 66.3% Oman N.R N.R 0.1% 0.3% 0.0% N.R 58.3% N.R Qatar N.R 1.1% 0.8% 0.6% N.R N.R N.R N.R Saudi Arabia 83.3% 7.6% 48.3% 92.3% 30.0% 23.5% 29.9% 30.7% UAE N.R 0.3% 0.7% 4.2% N.R N.R N.R 3.0% Aly M, Balkhy HH. Antimicrob Resist Infect Control. 2012; 1: 26

18 The prevalence of antimicrobial resistance in clinical isolates from Gulf Corporation Council Countries Geographical distributions of resistant isolates among GCC countries Aly M, Balkhy HH. Antimicrob Resist Infect Control. 2012; 1: 26

19 Location Riyadh, Saudi Arabia Abu Dhabi, United Arab Emirates Molecular Characterization of Carbapenemase-Producing Escherichia coli and Klebsiella pneumoniae in the Countries of the Gulf Cooperation Council: Dominance of OXA-48 and NDM Producers Summary of CRE clinical isolates in the GCC states: Kuwait, Kuwait Muscat, Oman Hospital name King Abdulaziz Medical City Sheikh Zayed Military Hospital Al-Ameri Hospital The Royal Hospital Hospital type Tertiary and academic Hospital capacity (no. of beds) Semiautom ated system used for species identification Study and isolates antibiotic received sensitivity (no.) 1,000 Vitek II, biomérieux Tertiary 365 Vitek II, biomérieux Tertiary 398 Vitek II, biomérieux Teaching tertiary 750 Phoenix, Becton, Dickinson No. (%) of isolates with reduced susceptibilit y to ertapenem No. (%) of carbapenemase and CTX-M-15-type genes No. (%) of plasmid replicon typing a NDM type OXA-48 type KPC type IMP type VIM type CTX-M-15 type IncL/M IncA/C E. coli (151) 2 (1.3) 1 (50) (100) NT b NT K. pneumoniae (77) 40 (52) 10 (25) 31 (77.5) c (70) 23 (74) 1 (3) E. coli (29) 1 (3) (100) NT NT K. 4 (25) 3 (75) (100) NT NT pneumoniae (16) E. coli (18) 0 NA d NA NA NA NA NA NT NT K. 0 NA NA NA NA NA NA NT NT pneumoniae (13) E. coli (23) 2 (9) (50) NT NT K. pneumoniae (14) 3 (21) 1 (33) 1 (33) (100) 0 0 Hosam M. Zowawi et al. Antimicrob. Agents Chemother. 2014;58:

20 Molecular Characterization of Carbapenemase-Producing Escherichia coli and Klebsiella pneumoniae in the Countries of the Gulf Cooperation Council: Dominance of OXA-48 and NDM Producers Summary of CRE clinical isolates in the GCC states: Doha, Qatar Manama, Bahrain Total E. coli K. pneumo niae Hamad Medical Coopera tion Samlani ya Medical Comple x Tertiary >1,300 Phoenix, Becton, Dickinso n Tertiary and teaching 1,000 Phoenix, Becton, Dickinso n E. coli (23) K. pneumo niae (16) E. coli (22) K. pneumo niae (11) 4 (17) 0 1 (25) (75) (31) 1 (20) 2 (40) (100) 0 1 (8) 0 NA NA NA NA NA NA NT NT 1 (0.9) (100) NT NT 266 (64) 9 (3.4) 1 (6) 1 (6.4) (78) (36) 53 (36) 15 (28) 34 (63) c (77) 23 (68) 2 (5.9) (15) (49) (77) 23 (66) 2 (5.7) Hosam (22.5) M. Zowawi et al. Antimicrob. Agents Chemother. 2014;58:

21 Evidence-Based Antimicrobial Stewardship Initiatives in Jordan Improve Antibiotic Prophylaxis for Cesarean Section A recent study conducted by the Jordan Food and Drug Administration (JFDA) found antimicrobials used for prophylaxis during common surgical procedures, like cesarean section, were frequently administered inconsistently or inappropriately Systems for Improved Access to pharmaceuticals and services (SIAPS) provided technical assistance to three hospitals in Jordan to strengthen antibiotic prophylaxis practices for cesarean section. Jordan Food and drug Administration. Rational antibiotic use in Jordan: auditing antibiotic use targeting surgical prophylaxis at Jordanian hospitals. JFDA, Rational Drug use department, may 2009 Gammouh s. and Joshi m Improving Antibiotic Prophylaxis in Cesarean Section in Jordanian Hospitals: SIAPS Technical Report. Arlington, VA: management sciences

22 Evidence-Based Antimicrobial Stewardship Initiatives in Jordan Improve Antibiotic Prophylaxis for Cesarean Section Results from all three hospitals indicate good compliance to the protocols and procedures as measured by the use of the preferred prophylactic antibiotic (cefazolin), the timing of administration, and the number of doses administered. Average surgical site infection rate of 1.59% (within international rates) Average cost for antibiotic prophylaxis per case decreased by 79% The hospitals experienced cost savings of approximately 10,905 Jordanian dinars, or 15,397 USD, in Based on the experience from the three hospitals Gammouh s. and Joshi m Improving Antibiotic Prophylaxis in Cesarean Section in Jordanian Hospitals: SIAPS Technical Report. Arlington, VA: management sciences

23 Evidence-Based Antimicrobial Stewardship Initiatives in Jordan Improve Antibiotic Prophylaxis for Cesarean Section Indicator Correct antibiotic use 0% 86% Correct timing of first dose (less than one hour before skin incision) Correct number of doses (single dose except for pre-identified exceptions) 0% 92% 0% 88% Gammouh s. and Joshi m Improving Antibiotic Prophylaxis in Cesarean Section in Jordanian Hospitals: SIAPS Technical Report. Arlington, VA: management sciences

24 Evidence-Based Antimicrobial Stewardship Initiatives in Jordan Improve Antibiotic Prophylaxis for Cesarean Section Based on the result of this study: Antibiotic prophylaxis protocol for cesarean section developed and mandated for all MOH hospitals providing ob/gyn services. Initiation of similar programs by other hospitals not included in the initial pilot Expansion to other surgical procedures (hernia). Contributed to Health Care Accreditation Agency s national quality and safety goals, one of which is appropriate use of prophylactic antibiotics during surgeries. Gammouh s. and Joshi m Improving Antibiotic Prophylaxis in Cesarean Section in Jordanian Hospitals: SIAPS Technical Report. Arlington, VA: management sciences

25 KFSHRC Experience

26 Antimicrobial Utilization & Evaluation (AUE) Subcommittee Established at KFSH&RC in 1994 Promote optimal antimicrobial therapy Prevent antimicrobial-related complications Evaluate the effectiveness of antimicrobial therapy Improve patient care & establish interdisciplinary consensus on antimicrobial use process. ASP is the systematic, coordinated implementation of the policies of AUE.

27 Effectiveness? MICU. July 2009-December patients 52% of initial therapy was not appropriate (47/90) No empirical therapy was initiated (19) Bug is resistant to the drug chosen (17) Failure to de-escalate ( 6) Wrong dose (3) Treatment of colonization (2)

28 90% of use was 5 drugs Drug Total cost of empiric tx Total cost of de-escalation tx Total Meropenem 34,484 38,718 73,202 Imipenem 13,025 17,013 30,038 Tigecycline 42,375 32,250 74,625 Piperacillin /tazobactam 48,679 45,682 94,361 Vancomycin 27,448 9,418 36,866 Cost of these 5 agents 166, , ,092 Total cost of All studied drugs 175, , ,836

29 So we are doing good things, but need to do better Activity Current Status at KFSH&RC Proposal Prospective Audit with Intervention Under Consideration & Feedback The Next Big Step! Formulary Restriction & Active Assess compliance Preauthorization Education Some Enhance Guidelines / Clinical Pathways Antimicrobial order form (CPOE) Combination Therapy Some (Vancomycin, Febrile Neutropenia, Clostridium Difficile) Case by Case Basis Update existing Strategically implement new Develop care sets Streamline or De-Escalation Case by Case Basis 2 nd stage pilot Dosing optimization (including IV to PO conversion) Some Enhance with general and specific projects & program

30 Prospective Audit with Intervention & Feedback Systematic identification of patients at risk for inappropriate antimicrobial use Targeted antimicrobials, positive cultures etc. Assessment of appropriateness using criteria Gathering patient s data (diagnosis etc.) Develop & implement intervention (active) Contacting prescriber to recommend a change Measure outcome

31 Antimicrobial stewardship program implementation in a medical intensive care unit at a tertiary care hospital in Saudi Arabia Appropriateness Definition Use optimum antibiotic regimen with regards to dose, frequency, route, and selecting the right antimicrobial agent for disease state and organism according to - Internal criteria (formulary restrictions) - Credible international guidelines Annals of Saudi Medicine. 03/2012; 33(6):547-54

32 Study Objectives Primary Objective Compare the appropriateness rate of empirical antibiotics therapy before and after implementation of proactive antimicrobial stewardship program Secondary Objectives The rate of clostridium difficile-associated diarrhea (CDAD) Frequency of MDR including methicillin-resistant staphylococcus aureus (MRSA), extended spectrum betalactamases producing strains (ESBL) Primary team acceptance rate for the ASP

33 Statistical Analysis Study Hypothesis: The appropriateness rate of empirical antibiotics therapy will be higher post ASP implementation Sample Size Calculation: N= 73 participants (49 in historical control arm and 24 in active ASP arm) based on alpha of 0.05 would yield 90 % power to detect a difference of 20 % between groups for the primary outcome Descriptive data were analyzed by using chi-square test for categorical data and student t-test for continuous data. The commercial software SPSS system (version 19) was used for statistical analysis.

34 Study Result Baseline Characteristics & Demographics Arm Control N= 49 Active ASP N=24 P value Gender Male, no. ( %) Female, no. ( %) 31 (63 %) 18 (37 %) 15 (63%) 9 (38%) Age (mean years) (interquartile range) APACHE II score* (mean) < *APACHE II score was calculated within 24 hours of ICU admission

35 Study Result Baseline Characteristics & Co-morbidities 100% 90% 80% 70% 60% 50% 40% 30% 20% 10% 0% Hospitali zation > 5 days * * * Broad steroid spectrum use > 2 AB > 7- wk 14 days MV Hospitali zation within 90 days of disease onset Historical control Active ASP % No significant differences between historical control and active ASP arm except for the factors presented with red asterisks (P < 0.05) vasopressor / ESRD DM Dialysis use Immun ologic deficit COPD: chronic obstructive pulmonary disease, DM: diabetes mellitus, ESRD: end stage renal disease, MV: mechanical ventilation, SOT: solid organ transplant >10 mg Predn isone * Severe Structur SOT MRSA COPD al Lung coloniz Disease ation * long Home term infusion care facility Reside nce Prior influe nza 4 Head ANC < Trauma 1,500 4% 0

36 Study Results Primary Outcomes (Empirical Antibiotics Therapy Appropriateness) Arm Control N= 49 Active ASP N=24 P value Initial appropriateness * Appropriate, no. ( %) Inappropriate, no. ( %) Final appropriateness * Appropriate, no. ( %) Inappropriate, no. ( %) 15 (30.6%) 5 (20.8%) (69.38%) 1 9 (79.1%) 15 (30.6%) 24 (100%) (69.38%) 0 (0 %) * Initial antibiotics appropriateness was defined as the first intervention initiated by physicians * Final antibiotics appropriateness was assessed following ASP team interventions

37 Study Results Reasons of initial antibiotics inappropriateness, no. Arm Control * N= 49 Active ASP ** N=24 P value No current treatment for positive culture No indication (e.g. colonization) for current treatment Inadequate empiric coverage for indication Excessive empiric coverage for indication Resistant to current antibiotic Regimen excessive (failure to de-escalate) Regimen inadequate (wrong dose or frequency) Total * In the historical control arm: each patients with initial inappropriate AB(34 pts) had 1 reason for inappropriateness ** In the active ASP arm: each patients with initial inappropriate AB (19 pts) had 1 reason for inappropriateness

38 Study Results Interventions made in the active ASP arm to overcome inappropriateness *, No. (%) Discontinue unnecessary antimicrobial therapy 2 (10.50%) 4 (21.10%) 17 (89.50%) 4 (21.10%) Change to drug of choice (more effective, narrower spectrum, more efficient.) Change to broader spectrum antimicrobial Regimen optimization Note: A total of 27 interventions were made, with an acceptance rate of 26 (96.3 %) and 1 (3.7 % ) accepted with minor modifications * In the active ASP arm: each patient with inappropriate AB (19 pts) had 1 interventions

39 Secondary Outcomes Arm Control N= Active ASP P value 49 N=24 Clostridium difficile-associated diarrhea (CDAD) 1 (2 %) 0 (0 %) 1 Microbiological outcome* MDR, no. ( %) MRSA, no. ( %) ESBL, no. ( %) MRSA/MDR, no. ( %) Patients ICU course Deceased, no. ( %) Transferred to floor, no. ( %) Transfer to another hospital, no. ( %) Still active at the MICU, no. ( %) Study Results 15 (30.6%) 2 (8.3%) (4.1 %) 0 (0 %) 1 11 (22.4%) 3 (12.5%) (2%) 0 (0 %) 1 16 ( 32.65%) 4 (16.7%) (59.2%) 20 (83.3%) (2%) 0 (0 %) 1 3 (6.1 %) 0 (0 %) 0.55 *Microbiological outcome is defined according to susceptibility reporting test from KFSHRC microbiology lab

40 Average Cost (SR) Study Results Direct Cost of Antibiotics Utilization Per Patient in Both Groups Average cost of Historical control arm Post hoc analysis showed ASP implementation resulted in average cost deduction by 125 SR as compared to historical control arm

41 How to Implement Active Intervention Component? You need a plan! Tailored to your institution Relates to existing committees, practitioners Respects available resources (especially people) Focuses in an area & with a design to show benefit Builds the case for getting more resources & expanding to other patient care areas Is efficient and evidenced based

42 Barriers to Establishing ASPs Lack of funding Shortage of adequately trained ID physicians and ID pharmacists Lack of pharmacy leadership supporting / managing ASP Lack of infectious diseases support Competition for funding with other hospital programs Communications with antagonizing colleagues Owens RC, Shorr AF, Deschambeault AL. Antimicrobial stewardship: shepherding precious resources. Am J Health-Syst Pharm. 2009; 66(Suppl 4):S15-22

Stewardship: Challenges & Opportunities in the Gulf Region

Stewardship: Challenges & Opportunities in the Gulf Region Stewardship: Challenges & Opportunities in the Gulf Region Mushira Enani, MBBS, FRCPE, FACP,CIC Head- Infectious Disease Section King Fahad Medical City Outline Background of Healthcare system in GCC GCC

More information

UPDATE ON ANTIMICROBIAL STEWARDSHIP REGULATIONS AND IMPLEMENTATION OF AN AMS PROGRAM

UPDATE ON ANTIMICROBIAL STEWARDSHIP REGULATIONS AND IMPLEMENTATION OF AN AMS PROGRAM UPDATE ON ANTIMICROBIAL STEWARDSHIP REGULATIONS AND IMPLEMENTATION OF AN AMS PROGRAM Diane Rhee, Pharm.D. Associate Professor of Pharmacy Practice Roseman University of Health Sciences Chair, Valley Health

More information

Healthcare Facilities and Healthcare Professionals. Public

Healthcare Facilities and Healthcare Professionals. Public Document Title: DOH Guidelines for Antimicrobial Stewardship Programs Document Ref. Number: DOH/ASP/GL/1.0 Version: 1.0 Approval Date: 13/12/2017 Effective Date: 14/12/2017 Document Owner: Applies to:

More information

Optimizing Antimicrobial Stewardship Activities Based on Institutional Resources

Optimizing Antimicrobial Stewardship Activities Based on Institutional Resources Optimizing Antimicrobial Stewardship Activities Based on Institutional Resources Andrew Hunter, PharmD, BCPS Infectious Diseases Clinical Pharmacy Specialist Michael E. DeBakey VA Medical Center Andrew.hunter@va.gov

More information

ANTIBIOTIC STEWARDSHIP

ANTIBIOTIC STEWARDSHIP ANTIBIOTIC STEWARDSHIP S.A. Dehghan Manshadi M.D. Assistant Professor of Infectious Diseases and Tropical Medicine Tehran University of Medical Sciences Issues associated with use of antibiotics were recognized

More information

Antimicrobial Stewardship. October 2012

Antimicrobial Stewardship. October 2012 Antimicrobial Stewardship October 2012 Rising Antimicrobial Resistance Methicillin resistant staphylococcus aureus (MRSA) Vancomycin resistant enterococci (VRE) MDR and extremely drug resistant (XDR TB)

More information

Antimicrobial Stewardship 101

Antimicrobial Stewardship 101 Antimicrobial Stewardship 101 Betty P. Lee, Pharm.D. Pediatric Infectious Disease/Antimicrobial Stewardship Pharmacist Lucile Packard Children s Hospital Stanford Disclosure I have no actual or potential

More information

Jump Starting Antimicrobial Stewardship

Jump Starting Antimicrobial Stewardship Jump Starting Antimicrobial Stewardship Amanda C. Hansen, PharmD Pharmacy Operations Manager Carilion Roanoke Memorial Hospital Roanoke, Virginia March 16, 2011 Objectives Discuss guidelines for developing

More information

Commonwealth of Kentucky Antibiotic Stewardship Practice Assessment For Long-Term Care Facilities

Commonwealth of Kentucky Antibiotic Stewardship Practice Assessment For Long-Term Care Facilities Commonwealth of Kentucky Antibiotic Stewardship Practice Assessment For Long-Term Care Facilities Introduction As the problem of antibiotic resistance continues to worsen in all healthcare setting, we

More information

Antimicrobial stewardship

Antimicrobial stewardship Antimicrobial stewardship Magali Dodemont, Pharm. with the support of Wallonie-Bruxelles International WHY IMPLEMENT ANTIMICROBIAL STEWARDSHIP IN HOSPITALS? Optimization of antimicrobial use To limit the

More information

Antimicrobial Stewardship in the Hospital Setting

Antimicrobial Stewardship in the Hospital Setting GUIDE TO INFECTION CONTROL IN THE HOSPITAL CHAPTER 12 Antimicrobial Stewardship in the Hospital Setting Authors Dan Markley, DO, MPH, Amy L. Pakyz, PharmD, PhD, Michael Stevens, MD, MPH Chapter Editor

More information

The International Collaborative Conference in Clinical Microbiology & Infectious Diseases

The International Collaborative Conference in Clinical Microbiology & Infectious Diseases The International Collaborative Conference in Clinical Microbiology & Infectious Diseases PLUS: Antimicrobial stewardship in hospitals: Improving outcomes through better education and implementation of

More information

Impact of Antimicrobial Stewardship Program

Impact of Antimicrobial Stewardship Program Impact of Antimicrobial Stewardship Program Ripal Joshi, Pharm.D. AAHIVP Tampa General Hospital January 28, 2016 Objectives Provide an overview on antimicrobial stewardship programs (ASP) Describe the

More information

ASCENSION TEXAS Antimicrobial Stewardship: Practical Implementation Strategies

ASCENSION TEXAS Antimicrobial Stewardship: Practical Implementation Strategies ASCENSION TEXAS Antimicrobial Stewardship: Practical Implementation Strategies Theresa Jaso, PharmD, BCPS (AQ-ID) Network Clinical Pharmacy Specialist Infectious Diseases Seton Healthcare Family Ascension

More information

Antimicrobial Stewardship:

Antimicrobial Stewardship: Antimicrobial Stewardship: Inpatient and Outpatient Elements Angela Perhac, PharmD afperhac@carilionclinic.org Disclosure I have no relevant finances to disclose. Objectives Review the core elements of

More information

Antibiotic Stewardship in the Hospital Setting

Antibiotic Stewardship in the Hospital Setting Antibiotic Stewardship in the Hospital Setting G. Evans, MD FRCPC Medical Director, Infection Prevention & Control Kingston General Hospital & Hotel Dieu Hospital EOPIC September 26, 2012 Stewardship stew-ard-ship

More information

Antimicrobial Stewardship Strategy:

Antimicrobial Stewardship Strategy: Antimicrobial Stewardship Strategy: Prospective audit with intervention and feedback Formal assessment of antimicrobial therapy by trained individuals, who make recommendations to the prescribing service

More information

Antimicrobial Stewardship Programs The Same, but Different. Sara Nausheen, MD Kevin Kern, PharmD

Antimicrobial Stewardship Programs The Same, but Different. Sara Nausheen, MD Kevin Kern, PharmD Antimicrobial Stewardship Programs The Same, but Different Sara Nausheen, MD Kevin Kern, PharmD Antimicrobial Stewardship Programs The Same, but Different Objectives: Outline the overall function of an

More information

Antibiotic Stewardship in Nursing Homes SAM GUREVITZ PHARM D, CGP ASSOCIATE PROFESSOR BUTLER UNIVERSITY COLLEGE OF PHARMACY AND HEALTH SCIENCE

Antibiotic Stewardship in Nursing Homes SAM GUREVITZ PHARM D, CGP ASSOCIATE PROFESSOR BUTLER UNIVERSITY COLLEGE OF PHARMACY AND HEALTH SCIENCE Antibiotic Stewardship in Nursing Homes SAM GUREVITZ PHARM D, CGP ASSOCIATE PROFESSOR BUTLER UNIVERSITY COLLEGE OF PHARMACY AND HEALTH SCIENCE Crisis: Antibiotic Resistance Success Strategy WWW.optimistic-care.org

More information

It s Time to Regulate Antimicrobial Stewardship Standards in Acute Care Settings. Emily Heil, PharmD, BCPS-AQ ID, AAHIVP

It s Time to Regulate Antimicrobial Stewardship Standards in Acute Care Settings. Emily Heil, PharmD, BCPS-AQ ID, AAHIVP It s Time to Regulate Antimicrobial Stewardship Standards in Acute Care Settings Emily Heil, PharmD, BCPS-AQ ID, AAHIVP Conflict of Interest I have no conflicts of interest to disclose related to the content

More information

Dr. Charles Onunkwo, Infectious Disease Medicine Erika Ingram, Infectious Disease/Critical Care Clinical Pharmacy Specialist Southeastern Regional

Dr. Charles Onunkwo, Infectious Disease Medicine Erika Ingram, Infectious Disease/Critical Care Clinical Pharmacy Specialist Southeastern Regional Dr. Charles Onunkwo, Infectious Disease Medicine Erika Ingram, Infectious Disease/Critical Care Clinical Pharmacy Specialist Southeastern Regional Medical Center Cancer Treatment Centers of America May

More information

11/22/2016. Antimicrobial Stewardship Update Disclosures. Outline. No conflicts of interest to disclose

11/22/2016. Antimicrobial Stewardship Update Disclosures. Outline. No conflicts of interest to disclose Antimicrobial Stewardship Update 2016 APIC-CI Conference November 17 th, 2016 Jay R. McDonald, MD Chief, ID Section VA St. Louis Health Care System Assistant Professor of medicine Washington University

More information

The Rise of Antibiotic Resistance: Is It Too Late?

The Rise of Antibiotic Resistance: Is It Too Late? The Rise of Antibiotic Resistance: Is It Too Late? Paul D. Holtom, MD Professor of Medicine and Orthopaedics USC Keck School of Medicine None DISCLOSURES THE PROBLEM Antibiotic resistance is one of the

More information

Misericordia Community Hospital (MCH) Antimicrobial Stewardship Report. July December 2013 Second and Third Quarters 2014

Misericordia Community Hospital (MCH) Antimicrobial Stewardship Report. July December 2013 Second and Third Quarters 2014 H e a l i n g t h e B o d y E n r i c h i n g t h e M i n d N u r t u r i n g t h e S o u l Misericordia Community Hospital (MCH) Antimicrobial Stewardship Report July December 213 Second and Third Quarters

More information

Identifying Medicine Use Problems Using Indicator-Based Studies in Health Facilities

Identifying Medicine Use Problems Using Indicator-Based Studies in Health Facilities Identifying Medicine Use Problems Using Indicator-Based Studies in Health Facilities Review of the Cesarean-section Antibiotic Prophylaxis Program in Jordan and Workshop on Rational Medicine Use and Infection

More information

Updates in Antimicrobial Stewardship

Updates in Antimicrobial Stewardship Updates in Antimicrobial Stewardship Andrew Hunter, Pharm.D., BCPS Infectious Diseases Clinical Pharmacy Specialist Michael E. DeBakey VA Medical Center andrew.hunter@va.gov Disclosures No disclosures

More information

MDRO s, Stewardship and Beyond. Linda R. Greene RN, MPS, CIC

MDRO s, Stewardship and Beyond. Linda R. Greene RN, MPS, CIC MDRO s, Stewardship and Beyond Linda R. Greene RN, MPS, CIC linda_greene@urmc.rochester.edu Evolving Threat of Antimicrobial Resistance Why are MDROs important? Limited treatment options Associated with:

More information

Antimicrobial Stewardship-way forward. Dr. Sonal Saxena Professor Lady Hardinge Medical College New Delhi

Antimicrobial Stewardship-way forward. Dr. Sonal Saxena Professor Lady Hardinge Medical College New Delhi Antimicrobial Stewardship-way forward Dr. Sonal Saxena Professor Lady Hardinge Medical College New Delhi Lets save what we have! What is Antibiotic stewardship? Optimal selection, dose and duration of

More information

New Opportunities for Microbiology Labs to Add Value to Antimicrobial Stewardship Programs

New Opportunities for Microbiology Labs to Add Value to Antimicrobial Stewardship Programs New Opportunities for Microbiology Labs to Add Value to Antimicrobial Stewardship Programs Patrick R. Murray, PhD Senior Director, WW Scientific Affairs 2017 BD. BD, the BD Logo and all other trademarks

More information

Minnesota Guide to a Comprehensive. Antimicrobial Stewardship Program

Minnesota Guide to a Comprehensive. Antimicrobial Stewardship Program Minnesota Guide to a Comprehensive Antimicrobial Stewardship Program Getting Started Antimicrobial Stewardship Program Strategies July 2012 Draft 8.10.12 1 Table of Contents Introduction. 3 Getting Started

More information

Using Data to Track Antibiotic Use and Outcomes

Using Data to Track Antibiotic Use and Outcomes Using Data to Track Antibiotic Use and Outcomes Michelle Nemec, PharmD Thrifty White Drug Pharmacy Objectives Describe the Antibiotic Stewardship Core Element of tracking and the specific interventions

More information

Bugs, Drugs, and No More Shoulder Shrugs: The Role for Antimicrobial Stewardship in Long-term Care

Bugs, Drugs, and No More Shoulder Shrugs: The Role for Antimicrobial Stewardship in Long-term Care Bugs, Drugs, and No More Shoulder Shrugs: The Role for Antimicrobial Stewardship in Long-term Care Molly Curran, PharmD, BCPS Clinical Assistant Professor The University of Texas College of Pharmacy Clinical

More information

ANTIBIOTIC STEWARDSHIP. Brian Mayhue, Pharm D, CGP Director of Pharmacy Palm Beach Gardens Medical Center

ANTIBIOTIC STEWARDSHIP. Brian Mayhue, Pharm D, CGP Director of Pharmacy Palm Beach Gardens Medical Center ANTIBIOTIC STEWARDSHIP Brian Mayhue, Pharm D, CGP Director of Pharmacy Palm Beach Gardens Medical Center Antibiotic Resistance It is not difficult to make microbes resistant to penicillin in the laboratory

More information

Disclosures. Astellas. The Medicines Company. Theravance Biopharma

Disclosures. Astellas. The Medicines Company. Theravance Biopharma Disclosures Astellas The Medicines Company Theravance Biopharma Objectives Define antimicrobial stewardship using nationally accepted criteria Identify strategies to provide antimicrobial stewardship Review

More information

Antimicrobial Stewardship

Antimicrobial Stewardship Antimicrobial Stewardship Report: 11 th August 2016 Issue: As part of ensuring compliance with the National Safety and Quality Health Service Standards (NSQHS), Yea & District Memorial Hospital is required

More information

Antimicrobial stewardship: Quick, don t just do something! Stand there!

Antimicrobial stewardship: Quick, don t just do something! Stand there! Antimicrobial stewardship: Quick, don t just do something! Stand there! Stanley I. Martin, MD, FACP, FIDSA Director, Division of Infectious Diseases Director, Antimicrobial Stewardship Program Geisinger

More information

Preserving bacterial susceptibility Implementing Antimicrobial Stewardship Programs Debra A. Goff, Pharm.D., FCCP

Preserving bacterial susceptibility Implementing Antimicrobial Stewardship Programs Debra A. Goff, Pharm.D., FCCP Preserving bacterial susceptibility Implementing Antimicrobial Stewardship Programs Debra A. Goff, Pharm.D., FCCP Clinical Associate Professor Infectious Diseases Specialist The Ohio State University Medical

More information

Antibiotic Stewardship in the LTC Setting

Antibiotic Stewardship in the LTC Setting Antibiotic Stewardship in the LTC Setting Joe Litsey, Director of Consulting Services Pharm.D., Board Certified Geriatric Pharmacist Thrifty White Pharmacy Objectives Describe the Antibiotic Stewardship

More information

Antimicrobial Stewardship in the Long Term Care and Outpatient Settings. Carlos Reyes Sacin, MD, AAHIVS

Antimicrobial Stewardship in the Long Term Care and Outpatient Settings. Carlos Reyes Sacin, MD, AAHIVS Antimicrobial Stewardship in the Long Term Care and Outpatient Settings Carlos Reyes Sacin, MD, AAHIVS Disclosure Speaker and consultant in HIV medicine for Gilead and Jansen Pharmaceuticals Objectives

More information

Potential Conflicts of Interest. Schematic. Reporting AST. Clinically-Oriented AST Reporting & Antimicrobial Stewardship

Potential Conflicts of Interest. Schematic. Reporting AST. Clinically-Oriented AST Reporting & Antimicrobial Stewardship Potential Conflicts of Interest Clinically-Oriented AST Reporting & Antimicrobial Stewardship Hsu Li Yang 27 th September 2013 Research Funding: Pfizer Singapore AstraZeneca Janssen-Cilag Merck, Sharpe

More information

Antimicrobial Stewardship

Antimicrobial Stewardship Antimicrobial Stewardship Preventing the Spread of Antibiotic Resistance and Improving Patient Care (Adapted from the Centers for Disease Control and Prevention) What is Stewardship? Antimicrobial stewardship

More information

Why Antimicrobial Stewardship?

Why Antimicrobial Stewardship? Antimicrobial Stewardship: Why and How CAPT Arjun Srinivasan, MD Associate Director for Healthcare Associated Infection Prevention Programs Division of Healthcare Quality Promotion Why Antimicrobial Stewardship?

More information

Best Practices: Goals of Antimicrobial Stewardship

Best Practices: Goals of Antimicrobial Stewardship Best Practices: Goals of Antimicrobial Stewardship Gail Scully, M.D, M.P.H. and Elizabeth Radigan, PharmD, BCPS UMass Memorial Medical Center Division of Infectious Disease Department of Medicine September

More information

St. Joseph s General Hospital Vegreville. and. Mary Immaculate Care Centre. Antimicrobial Stewardship Report

St. Joseph s General Hospital Vegreville. and. Mary Immaculate Care Centre. Antimicrobial Stewardship Report St. Joseph s General Hospital Vegreville and Mary Immaculate Care Centre Antimicrobial Stewardship Report January to June 217 Introduction Antibiotics are among the most commonly prescribed medications

More information

Jump Start Stewardship

Jump Start Stewardship Jump Start Stewardship Webinar 2: Building your Stewardship Team and Selecting Interventions and Targets for your Implementation Welcome Thank you for your time today This webinar will be recorded for

More information

Executive Summary: A Point Prevalence Survey of Antimicrobial Use: Benchmarking and Patterns of Use to Support Antimicrobial Stewardship Efforts

Executive Summary: A Point Prevalence Survey of Antimicrobial Use: Benchmarking and Patterns of Use to Support Antimicrobial Stewardship Efforts Executive Summary: A Point Prevalence Survey of Antimicrobial Use: Benchmarking and Patterns of Use to Support Antimicrobial Stewardship Efforts Investigational Team: Diane Brideau-Laughlin BSc(Pharm),

More information

MAGNITUDE OF ANTIMICROBIAL USE. Antimicrobial Stewardship in Acute and Long Term Healthcare Facilities: Design, Implementation and Challenges

MAGNITUDE OF ANTIMICROBIAL USE. Antimicrobial Stewardship in Acute and Long Term Healthcare Facilities: Design, Implementation and Challenges Antimicrobial Stewardship in Acute and Long Term Healthcare Facilities: Design, Implementation and Challenges John A. Jernigan, MD, MS Division of Healthcare Quality Promotion Centers for Disease Control

More information

ANTIBIOTICS IN THE ER:

ANTIBIOTICS IN THE ER: ANTIBIOTICS IN THE ER: EXPLORING THE ROLE OF ANTIMICROBIAL STEWARDSHIP IN THE EMERGENCY DEPARTMENT ANGELINA DAVIS, PHARMD, MS, BCPS (AQ-ID) LIAISON CLINICAL PHARMACIST DUKE ANTIMICROBIAL STEWARDSHIP OUTREACH

More information

Antimicrobial Stewardship Program 2 nd Quarter

Antimicrobial Stewardship Program 2 nd Quarter Antimicrobial Stewardship Program 2 nd Quarter May 19, 2016 Jill Hanson, WHA DeAnn Richards, MetaStar Objectives for Today Hospital Highlight UnityPoint Health - Meriter Status of the state Update on pilot

More information

Antimicrobial Stewardship

Antimicrobial Stewardship Antimicrobial Stewardship Background Why Antimicrobial Stewardship 30-50% of antibiotic use in hospitals are unnecessary or inappropriate Appropriate antimicrobial use is a medication-safety and patient-safety

More information

1. List three activities pharmacists can implement to support. 2. Identify potential barriers to implementing antimicrobial

1. List three activities pharmacists can implement to support. 2. Identify potential barriers to implementing antimicrobial OPTIMIZING ANTIMICROBIAL STEWARDSHIP: IT STARTS IN THE EMERGENCY DEPARTMENT! 1 2 Objectives 1. List three activities pharmacists can implement to support health-system antimicrobial stewardship programs

More information

Inappropriate Use of Antibiotics and Clostridium difficile Infection. Jocelyn Srigley, MD, FRCPC November 1, 2012

Inappropriate Use of Antibiotics and Clostridium difficile Infection. Jocelyn Srigley, MD, FRCPC November 1, 2012 Inappropriate Use of Antibiotics and Clostridium difficile Infection Jocelyn Srigley, MD, FRCPC November 1, 2012 Financial Disclosures } No conflicts of interest } The study was supported by a Hamilton

More information

8/17/2016 ABOUT US REDUCTION OF CLOSTRIDIUM DIFFICILE THROUGH THE USE OF AN ANTIMICROBIAL STEWARDSHIP PROGRAM

8/17/2016 ABOUT US REDUCTION OF CLOSTRIDIUM DIFFICILE THROUGH THE USE OF AN ANTIMICROBIAL STEWARDSHIP PROGRAM Mary Moore, MS CIC MT (ASCP) Infection Prevention Coordinator Great River Medical Center, West Burlington REDUCTION OF CLOSTRIDIUM DIFFICILE THROUGH THE USE OF AN ANTIMICROBIAL STEWARDSHIP PROGRAM ABOUT

More information

Antibiotic Stewardship Program (ASP) CHRISTUS SETX

Antibiotic Stewardship Program (ASP) CHRISTUS SETX Antibiotic Stewardship Program (ASP) CHRISTUS SETX Program Goals I. Judicious use of antibiotics Decrease use of broad spectrum antibiotics and deescalate use based on clinical symptoms Therapeutic duplication:

More information

Antimicrobial Stewardship Strategy: Dose optimization

Antimicrobial Stewardship Strategy: Dose optimization Antimicrobial Stewardship Strategy: Dose optimization Review and individualization of antimicrobial dosing based on the characteristics of the patient, drug, and infection. Description This is an overview

More information

Define evidence based practices for selection and duration of antibiotics to treat suspected or confirmed neonatal sepsis

Define evidence based practices for selection and duration of antibiotics to treat suspected or confirmed neonatal sepsis GLOBAL AIM: Antibiotic Stewardship Perinatal Quality Improvement Teams (PQITs) will share strategies and lessons learned to develop potentially better practices and employ QI methodologies to establish

More information

Overview of Infection Control and Prevention

Overview of Infection Control and Prevention Overview of Infection Control and Prevention Review of the Cesarean-section Antibiotic Prophylaxis Program in Jordan and Workshop on Rational Medicine Use and Infection Control Terry Green and Salah Gammouh

More information

Grey Nuns Community Hospital (GNCH) Antimicrobial Stewardship Report

Grey Nuns Community Hospital (GNCH) Antimicrobial Stewardship Report H e a l i n g t h e B o d y E n r i c h i n g t h e M i n d N u r t u r i n g t h e S o u l Grey Nuns Community Hospital (GNCH) Antimicrobial Stewardship Report to 214 Table of Contents I. Introduction..

More information

Hospital Antimicrobial Stewardship Program Assessment Checklist

Hospital Antimicrobial Stewardship Program Assessment Checklist Hospital Antimicrobial Stewardship Program Assessment Checklist This checklist should be used to determine which aspects of antimicrobial stewarship (AMS) programs are already in place to ensure optimal

More information

Promoting Appropriate Antimicrobial Prescribing in Secondary Care

Promoting Appropriate Antimicrobial Prescribing in Secondary Care Promoting Appropriate Antimicrobial Prescribing in Secondary Care Stuart Brown Healthcare Acquired Infection and Antimicrobial Resistance Project Lead NHS England March 2015 Introduction Background ESPAUR

More information

Appropriate antimicrobial therapy in HAP: What does this mean?

Appropriate antimicrobial therapy in HAP: What does this mean? Appropriate antimicrobial therapy in HAP: What does this mean? Jaehee Lee, M.D. Kyungpook National University Hospital, Korea KNUH since 1907 Presentation outline Empiric antimicrobial choice: right spectrum,

More information

CHAPTER 9 ANTIMICROBIAL STEWARDSHIP PROGRAM (ASP)

CHAPTER 9 ANTIMICROBIAL STEWARDSHIP PROGRAM (ASP) DEPARTMENT OF THE ARMY HEADQUARTERS, UNITED STATES ARMY MEDICAL DEPARTMENT ACTIVITY FORT POLK, LOUISIANA 71459-5110 MEDDAC Regulation 29 August 2017 Number 500a-59 CHAPTER 9 ANTIMICROBIAL STEWARDSHIP PROGRAM

More information

Antimicrobial Stewardship: Stopping the Spread of Antibiotic Resistance

Antimicrobial Stewardship: Stopping the Spread of Antibiotic Resistance Antimicrobial Stewardship: Stopping the Spread of Antibiotic Resistance Natalie Weber, PharmD PGY2 Critical Care Pharmacy Resident September 22, 2016 The speaker has no actual or potential conflicts of

More information

ANTIMICROBIAL RESISTANCE

ANTIMICROBIAL RESISTANCE Sunday, February 22, 2015 1 Abdullah M Assiri ANTIMICROBIAL RESISTANCE Local perspectives Abdullah M. Assiri, MD Assistant Deputy Minister for Preventive Medicine MOH, KSA Global threat The WHO Global

More information

Stewardship tools. Dilip Nathwani Ninewells Hospital and Medical School Dundee, UK

Stewardship tools. Dilip Nathwani Ninewells Hospital and Medical School Dundee, UK Stewardship tools Dilip Nathwani Ninewells Hospital and Medical School Dundee, UK What is Antimicrobial Stewardship (AMS)? Antimicrobial stewardship has been defined as the optimal selection, dosage, and

More information

PRACTIC GUIDELINES for APPROPRIATE ANTIBIOTICS USE

PRACTIC GUIDELINES for APPROPRIATE ANTIBIOTICS USE PRACTIC GUIDELINES for APPROPRIATE ANTIBIOTICS USE Global Alliance for Infection in Surgery World Society of Emergency Surgery (WSES) and not only!! Aims - 1 Rationalize the risk of antibiotics overuse

More information

Objective 1/20/2016. Expanding Antimicrobial Stewardship into the Outpatient Setting. Disclosure Statement of Financial Interest

Objective 1/20/2016. Expanding Antimicrobial Stewardship into the Outpatient Setting. Disclosure Statement of Financial Interest Expanding Antimicrobial Stewardship into the Outpatient Setting Michael E. Klepser, Pharm.D., FCCP Professor Pharmacy Practice Ferris State University College of Pharmacy Disclosure Statement of Financial

More information

Infection Control of Emerging Diseases

Infection Control of Emerging Diseases 2016 EPS Training Event Martin E. Evans, MD Director, VHA MDRO Program National Infectious Diseases Service Lexington, KY & Cincinnati, OH Infection Control of Emerging Diseases 2016 EPS Training Event

More information

Appropriate Antimicrobial Use in California: The Path of Least Resistance

Appropriate Antimicrobial Use in California: The Path of Least Resistance Appropriate Antimicrobial Use in California: The Path of Least Resistance BEACON Fall Exchange November 9, 2011 Kavita K. Trivedi, MD Healthcare Associated Infections Program California Department of Public

More information

Antimicrobial Stewardship/Statewide Antibiogram. Felicia Matthews Senior Consultant, Pharmacy Specialty BD MedMined Services

Antimicrobial Stewardship/Statewide Antibiogram. Felicia Matthews Senior Consultant, Pharmacy Specialty BD MedMined Services Antimicrobial Stewardship/Statewide Antibiogram Felicia Matthews Senior Consultant, Pharmacy Specialty BD MedMined Services Disclosures Employee of BD Corporation MedMined Services Agenda CMS and JCAHO

More information

EVIDENCE BASED MEDICINE: ANTIBIOTIC RESISTANCE IN THE ELDERLY CHETHANA KAMATH GERIATRIC MEDICINE WEEK

EVIDENCE BASED MEDICINE: ANTIBIOTIC RESISTANCE IN THE ELDERLY CHETHANA KAMATH GERIATRIC MEDICINE WEEK EVIDENCE BASED MEDICINE: ANTIBIOTIC RESISTANCE IN THE ELDERLY CHETHANA KAMATH GERIATRIC MEDICINE WEEK EPIDEMIOLOGY AND BACKGROUND Every year, more than 2 million people in the United States acquire antibiotic-resistant

More information

2016/LSIF/FOR/007 Improving Antimicrobial Use and Awareness in Korea

2016/LSIF/FOR/007 Improving Antimicrobial Use and Awareness in Korea 2016/LSIF/FOR/007 Improving Antimicrobial Use and Awareness in Korea Submitted by: Asia Pacific Foundation for Infectious Diseases Policy Forum on Strengthening Surveillance and Laboratory Capacity to

More information

Preventing and Responding to Antibiotic Resistant Infections in New Hampshire

Preventing and Responding to Antibiotic Resistant Infections in New Hampshire Preventing and Responding to Antibiotic Resistant Infections in New Hampshire Benjamin P. Chan, MD, MPH NH Dept. of Health & Human Services Division of Public Health Services May 23, 2017 To bring a greater

More information

03/09/2014. Infection Prevention and Control A Foundation Course. Talk outline

03/09/2014. Infection Prevention and Control A Foundation Course. Talk outline Infection Prevention and Control A Foundation Course 2014 What is healthcare-associated infection (HCAI), antimicrobial resistance (AMR) and multi-drug resistant organisms (MDROs)? Why we should be worried?

More information

Antimicrobial Stewardship

Antimicrobial Stewardship Antimicrobial Stewardship Annual Report 2015-2016 Prepared by the Fraser Health Antimicrobial Stewardship Program August 2016 Contents Executive Summary... 3 Background... 4 ASP Team Members... 5 Ackowledgements...

More information

Role of the general physician in the management of sepsis and antibiotic stewardship

Role of the general physician in the management of sepsis and antibiotic stewardship Role of the general physician in the management of sepsis and antibiotic stewardship Prof Martin Wiselka Dept of Infection and Tropical Medicine University Hospitals of Leicester Sepsis and antibiotic

More information

Dr. Torsten Hoppe-Tichy, Chief Pharmacist. How to implement Antibiotic Stewardship without having the resources for that?

Dr. Torsten Hoppe-Tichy, Chief Pharmacist. How to implement Antibiotic Stewardship without having the resources for that? Dr. Torsten Hoppe-Tichy, Chief Pharmacist How to implement Antibiotic Stewardship without having the resources for that? No conflict of interests Questions to the audience (Yes/No) - Is it promising to

More information

Hot Topics in Antimicrobial Stewardship. Meghan Brett, MD Medical Director, Antimicrobial Stewardship University of New Mexico Hospital

Hot Topics in Antimicrobial Stewardship. Meghan Brett, MD Medical Director, Antimicrobial Stewardship University of New Mexico Hospital Hot Topics in Antimicrobial Stewardship Meghan Brett, MD Medical Director, Antimicrobial Stewardship University of New Mexico Hospital Antimicrobial Stewardship Goals Primary Goal Optimize clinical outcomes

More information

What is an Antibiotic Stewardship Program?

What is an Antibiotic Stewardship Program? What is an Antibiotic Stewardship Program? Jane Rogers, R.N. Anne Messer, MPH Learning Session #4 August 15, 2017 National Nursing Home Quality Care Collaborative Change Package Change Bundle: To prevent

More information

Collecting and Interpreting Stewardship Data: Breakout Session

Collecting and Interpreting Stewardship Data: Breakout Session Collecting and Interpreting Stewardship Data: Breakout Session Michael S. Calderwood, MD, MPH Regional Hospital Epidemiologist, Dartmouth-Hitchcock Medical Center March 20, 2019 None Disclosures Outline

More information

Today s webinar will begin in a few minutes.

Today s webinar will begin in a few minutes. Today s webinar will begin in a few minutes. Please press *6 to mute your line or use the mute button on your phone. If you have questions for the presenter or need to contact TCPS staff, type your comments

More information

Antimicrobial Stewardship: Guidelines for its Implementation

Antimicrobial Stewardship: Guidelines for its Implementation Antimicrobial Stewardship: Guidelines for its Implementation Loliet Gonzalez Martinez, Pharm.D. Palmetto General Hospital PGY-1 Pharmacy Resident Disclosure The author of this presentation has nothing

More information

Telligen Outpatient Antibiotic Stewardship Initiative. The Renal Network March 1, 2017

Telligen Outpatient Antibiotic Stewardship Initiative. The Renal Network March 1, 2017 Telligen Outpatient Antibiotic Stewardship Initiative The Renal Network March 1, 2017 Who is Telligen? What is the QIN-QIO Program? Telligen: The Medicare Quality Innovation Network (QIN)-Quality Improvement

More information

EUROPEAN COMMISSION DIRECTORATE-GENERAL FOR HEALTH AND FOOD SAFETY REFERENCES: MALTA, COUNTRY VISIT AMR. STOCKHOLM: ECDC; DG(SANTE)/

EUROPEAN COMMISSION DIRECTORATE-GENERAL FOR HEALTH AND FOOD SAFETY REFERENCES: MALTA, COUNTRY VISIT AMR. STOCKHOLM: ECDC; DG(SANTE)/ EUROPEAN COMMISSION DIRECTORATE-GENERAL FOR HEALTH AND FOOD SAFETY Health and food audits and analysis REFERENCES: ECDC, MALTA, COUNTRY VISIT AMR. STOCKHOLM: ECDC; 2017 DG(SANTE)/2017-6248 EXECUTIVE SUMMARY

More information

REPORT ON THE ANTIMICROBIAL RESISTANCE (AMR) SUMMIT

REPORT ON THE ANTIMICROBIAL RESISTANCE (AMR) SUMMIT 1 REPORT ON THE ANTIMICROBIAL RESISTANCE (AMR) SUMMIT The Department of Health organised a summit on Antimicrobial Resistance (AMR) the purpose of which was to bring together all stakeholders involved

More information

MHA/OHA HIIN Antibiotic Stewardship/MDRO Collaborative

MHA/OHA HIIN Antibiotic Stewardship/MDRO Collaborative MHA/OHA HIIN Antibiotic Stewardship/MDRO Collaborative Place picture here Nov. 14, 2017 Reminders For best sound quality, dial in at 1-800-791-2345 and enter code 11076 Please use the chat box to ask questions!

More information

ANTIMICROBIAL STEWARDSHIP START SMART THEN FOCUS Guidance for Antimicrobial Stewardship for SHSCT

ANTIMICROBIAL STEWARDSHIP START SMART THEN FOCUS Guidance for Antimicrobial Stewardship for SHSCT ANTIMICROBIAL STEWARDSHIP START SMART THEN FOCUS Guidance for Antimicrobial Stewardship for SHSCT CLINICAL GUIDELINES ID TAG Title: Prepared by Specialty / Division: Directorate: Antimicrobial Stewardship

More information

Position Statement The Role of the ICP in Antimicrobial Stewardship

Position Statement The Role of the ICP in Antimicrobial Stewardship Position Statement The Role of the ICP in Antimicrobial Stewardship ACIPC Recommends Infection control practitioners bring specific expertise and should be part of a multidisciplinary antimicrobial stewardship

More information

Antimicrobial Stewardship Strategy: Antibiograms

Antimicrobial Stewardship Strategy: Antibiograms Antimicrobial Stewardship Strategy: Antibiograms A summary of the cumulative susceptibility of bacterial isolates to formulary antibiotics in a given institution or region. Its main functions are to guide

More information

Evaluating the Role of MRSA Nasal Swabs

Evaluating the Role of MRSA Nasal Swabs Evaluating the Role of MRSA Nasal Swabs Josh Arnold, PharmD PGY1 Pharmacy Resident Pharmacy Grand Rounds February 28, 2017 2016 MFMER slide-1 Objectives Identify the pathophysiology of MRSA nasal colonization

More information

Understanding the Hospital Antibiogram

Understanding the Hospital Antibiogram Understanding the Hospital Antibiogram Sharon Erdman, PharmD Clinical Professor Purdue University College of Pharmacy Infectious Diseases Clinical Pharmacist Eskenazi Health 5 Understanding the Hospital

More information

Overview of C. difficile infections. Kurt B. Stevenson, MD MPH Professor Division of Infectious Diseases

Overview of C. difficile infections. Kurt B. Stevenson, MD MPH Professor Division of Infectious Diseases Overview of C. difficile infections Kurt B. Stevenson, MD MPH Professor Division of Infectious Diseases Conflicts of Interest I have no financial conflicts of interest related to this topic and presentation.

More information

Antimicrobial Stewardship Protecting a Valuable Resource

Antimicrobial Stewardship Protecting a Valuable Resource Antimicrobial Stewardship Protecting a Valuable Resource November 8, 2011 Medical Director Communicable Disease Service NJDHSS Edward.Lifshitz@doh.state.nj.us (609) 826-5964 One can think of the middle

More information

Antibiotic Stewardship Beyond Hospital Walls

Antibiotic Stewardship Beyond Hospital Walls Antibiotic Stewardship Beyond Hospital Walls Katie Burenheide Foster, PharmD, MS, BCPS, FCCM Pharmacy Clinical Manager & PGY1 Pharmacy Residency Director OBJECTIVES 1. Review what Antibiotic Stewardship

More information

Antimicrobial Stewardship Esperienza Torinese

Antimicrobial Stewardship Esperienza Torinese Pisa 15 Novembre 2016 Antimicrobial Stewardship Esperienza Torinese Francesco G. De Rosa Dipartimento di Scienze Mediche Università di Torino Antimicrobial Stewardship First introduced by Dale Gerding

More information

Pharmacist-Driven ASP. Jessica Holt, PharmD, BCPS (AQ-ID) Infectious Diseases Pharmacy Coordinator October 24 th, 2013

Pharmacist-Driven ASP. Jessica Holt, PharmD, BCPS (AQ-ID) Infectious Diseases Pharmacy Coordinator October 24 th, 2013 Pharmacist-Driven ASP Jessica Holt, PharmD, BCPS (AQ-ID) Infectious Diseases Pharmacy Coordinator October 24 th, 2013 Abbott Northwestern Hospital Largest not-for-profit hospital in the Twin Cities area

More information

Antimicrobial utilization: Capital Health Region, Alberta

Antimicrobial utilization: Capital Health Region, Alberta ANTIMICROBIAL STEWARDSHIP Antimicrobial utilization: Capital Health Region, Alberta Regionalization of health care services in Alberta began in 1994. In the Capital Health region, restructuring of seven

More information

Workplan on Antibiotic Usage Management

Workplan on Antibiotic Usage Management IMPACT Forum: Antibiotic Guideline in Perspective Workplan on Antibiotic Usage Management Dr. Raymond Yung Consultant Microbiologist PYNEH 20 April 2002 May 2002 Dr. Raymond Yung 1 Objective 1. Heighten

More information

Implementing Antibiotic Stewardship in Rural and Critical Access Hospitals

Implementing Antibiotic Stewardship in Rural and Critical Access Hospitals National Center for Emerging and Zoonotic Infectious Diseases Implementing Antibiotic Stewardship in Rural and Critical Access Hospitals Denise Cardo, MD Director, Division of Healthcare Quality Promotion,

More information

Antimicrobial Stewardship Basics Why, What, Who, and How. Philip Chung, PharmD, MS, BCPS ASAP Community Network Pharmacy Coordinator October 12, 2017

Antimicrobial Stewardship Basics Why, What, Who, and How. Philip Chung, PharmD, MS, BCPS ASAP Community Network Pharmacy Coordinator October 12, 2017 Antimicrobial Stewardship Basics Why, What, Who, and How Philip Chung, PharmD, MS, BCPS ASAP Community Network Pharmacy Coordinator October 12, 2017 Objectives List reasons for developing antimicrobial

More information